SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-052094
Filing Date
2020-09-25
Accepted
2020-09-25 16:20:09
Documents
1
Period of Report
2020-09-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3135
  Complete submission text file 0001209191-20-052094.txt   4810
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O ARCA BIOPHARMA, INC 8001 ARISTA PLACE, STE 430 BROOMFIELD CO 80021
Business Address
CONWAY ROBERT E (Reporting) CIK: 0001184334 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 201200363